(-)-Curine
Code | Size | Price |
---|
TAR-TN1156-10mg | 10mg | £223.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TN1156-1mL | 1 mL * 10 mM (in DMSO) | £239.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
(-)-Curine can inhibit viability of hepatocellular carcinoma cells in regardless of p53 status.
CAS:
436-05-5
Formula:
C36H38N2O6
Molecular Weight:
594.708
Pathway:
Apoptosis
Purity:
0.98
SMILES:
COc1cc2CCN(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@@H](Cc7ccc(Oc(c1O)c23)cc7)N(C)CCc6cc5OC)c4
Target:
p53
References
(-)-Curine induces cell cycle arrest and cell death in hepatocellular carcinoma cells in a p53-independent way.Biomed Pharmacother. 2017 May;89:894-901.